<DOC>
	<DOCNO>NCT03059303</DOCNO>
	<brief_summary>The purpose study assess relative bioavailability single-dose Simeprevir ( SMV ) , Odalasvir ( ODV ) , AL-335 administer fixed-dose combination ( FDC ) compare single agent administer together , assess effect multiple-dose lansoprazole omeprazole single-dose pharmacokinetics ( PK ) SMV , ODV , AL-335 administer FDC .</brief_summary>
	<brief_title>Study Assess Relative Bioavailability Fixed-Dose Combination ( FDC ) Tablet ( Simeprevir , Odalasvir AL-335 ) Compared With Single Agents Administered Together , Assess Effect Multiple-Dose Lansoprazole Omeprazole Single-Dose Pharmacokinetics SMV , ODV , AL-335 ( FDC )</brief_title>
	<detailed_description />
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Simeprevir</mesh_term>
	<criteria>Participant must body mass index ( BMI : weight kg divide square height meter ) 18.0 32.0 kilogram per meter ( kg/m^2 ) , extremes include , body weight less 50.0 kg Participant must blood pressure ( supine least 5 minute rest ) 90 140 millimeter mercury ( mmHg ) systolic , inclusive , high 90 mmHg diastolic . If blood pressure range , 2 repeat assessment permit . Participants normal value retest may include Participant must normal 12lead Electrocardiogram [ ECG ] ( base mean value triplicate ECG parameter ) consistent normal cardiac conduction function screening , include : ) normal sinus rhythm ( heart rate ( HR ) 60 90 beat per minute [ bpm ] , extremes include ) ; b ) QT interval correct heart rate accord Fridericia 's formula ( QTcF ) less equal &lt; =450 millisecond ( m ) male participant &lt; =470 m female participant ; c ) QRS interval &lt; =110 m ; ) PR interval &lt; =200 m ; e ) Electrocardiogram ( ECG ) morphology consistent healthy cardiac conduction function . Any evidence heart block exclusionary . Any evidence leave right bundle branch block exclusionary Female participant , except postmenopausal , must negative serum ( betahuman chorionic gonadotropin ) pregnancy test screen Female participant must negative highly sensitive urine serum pregnancy test Day 1 Participant past history : ) Heart arrhythmia ( example , extrasystolic rhythms tachycardia rest ) . Isolated extrasystolic beat exclusionary ; b ) Risk factor associate Torsade de Pointes hypokalemia ; c ) Family history short/long QT syndrome ; ) Sudden unexplained death ( include sudden infant death syndrome ) first degree relative ( , sibling , offspring , biological parent ) Participant know allergy , hypersensitivity , intolerance odalasvir ( ODV ) , AL335 , simeprevir ( SMV ) , lansoprazole , omeprazole , excipients Participant history hepatitis B surface antigen ( HBsAg ) hepatitis C antibody ( antiHCV ) positive , clinically active liver disease , test positive HBsAg antiHCV screen Participant history human immunodeficiency virus ( HIV1 ) 2 infection positive , test positive HIV1 2 screen Participant previously dose SMV , ODV , AL335 3 singledose study multiple dose study SMV , ODV , AL335</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>